State Of Wisconsin Investment Board Clovis Oncology, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $72,627 - $341,234	-115,282 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$4.13 - $6.41 $2,891 - $4,487	-700 Reduced 0.6%	115,282 $553,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $120,500 - $193,000	25,000 Added 27.48%	115,982 $676,000
Q2 2020 Aug 12, 2020	SELL	$5.69 - $9.69 $49,503 - $84,303	-8,700 Reduced 8.73%	90,982 $614,000
Q1 2020 May 06, 2020	BUY	$3.77 - $11.0 $99,905 - $291,500	26,500 Added 36.21%	99,682 $634,000
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $22,401 - $87,495	5,700 Added 8.45%	73,182 $288,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $19,215 - $38,505	1,500 Added 2.27%	67,482 $1 Million
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $303,752 - $520,816	17,200 Added 35.26%	65,982 $1.64 Million
Q4 2018 Feb 11, 2019	BUY	$11.63 - $32.67 $3,489 - $9,801	300 Added 0.62%	48,782 $876,000
Q2 2018 Aug 03, 2018	BUY	$42.06 - $62.4 $227,124 - $336,960	5,400 Added 12.53%	48,482 $2.2 Million
Q3 2017 Nov 01, 2017	BUY	$67.17 - $84.81 $2.89 Million - $3.65 Million	43,082	43,082 $3.55 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.